0001193125-26-174461.txt : 20260423
0001193125-26-174461.hdr.sgml : 20260423
20260423212250
ACCESSION NUMBER: 0001193125-26-174461
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20260423
DATE AS OF CHANGE: 20260423
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Damora Therapeutics, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-91812
FILM NUMBER: 26890214
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: (781) 281-9020
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto, Inc.
DATE OF NAME CHANGE: 20201029
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Paramora Holding LLC
CENTRAL INDEX KEY: 0002103411
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 267-760-4066
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BUILDING 23, SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02453
SCHEDULE 13G/A
1
primary_doc.xml
X0202
SCHEDULE 13G/A
0002103411
XXXXXXXX
LIVE
1
Common Stock, par value $0.00001 per share
02/09/2026
0001800315
Damora Therapeutics, Inc.
36322Q206
221 Crescent Street
Building 23, Suite 105
Waltham
MA
02453
Rule 13d-1(c)
Paramora Holding LLC
DE
2045473
0.00
2045473
0.00
2045473
N
3.39
CO
Row 11 is based on 60,303,212 shares of Common Stock outstanding as of March 17, 2026 as reported in the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on March 19, 2026.
Damora Therapeutics, Inc.
221 Crescent St., Building 23, Suite 105, Waltham, MA 02453
Paramora Holding LLC
221 Crescent St., Building 23, Suite 105, Waltham, MA 02453
Delaware
Y
See the response to Item 9 on the attached cover page.
See the response to Item 11 on the attached cover page.
See the response to Item 5 on the attached cover page.
See the response to Item 6 on the attached cover page.
See the response to Item 7 on the attached cover page.
See the response to Item 8 on the attached cover page.
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Paramora Holding LLC
/s/ Keri Lantz
Keri Lantz, Treasurer
04/23/2026